Indaptus Therapeutics Statistics
Total Valuation
INDP has a market cap or net worth of $7.43 million. The enterprise value is $2.23 million.
Important Dates
The last earnings date was Thursday, March 13, 2025, before market open.
| Earnings Date | Mar 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
INDP has 14.43 million shares outstanding. The number of shares has increased by 11.36% in one year.
| Current Share Class | 14.43M |
| Shares Outstanding | 14.43M |
| Shares Change (YoY) | +11.36% |
| Shares Change (QoQ) | +14.87% |
| Owned by Insiders (%) | 34.17% |
| Owned by Institutions (%) | 4.42% |
| Float | 8.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.67 |
| P/TBV Ratio | 2.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.95, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.95 |
| Quick Ratio | 1.71 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -187.52% and return on invested capital (ROIC) is -117.98%.
| Return on Equity (ROE) | -187.52% |
| Return on Assets (ROA) | -86.28% |
| Return on Invested Capital (ROIC) | -117.98% |
| Return on Capital Employed (ROCE) | -389.51% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.15M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -76.29% in the last 52 weeks. The beta is 1.11, so INDP's price volatility has been higher than the market average.
| Beta (5Y) | 1.11 |
| 52-Week Price Change | -76.29% |
| 50-Day Moving Average | 0.80 |
| 200-Day Moving Average | 1.30 |
| Relative Strength Index (RSI) | 26.28 |
| Average Volume (20 Days) | 1,214,915 |
Short Selling Information
The latest short interest is 52,408, so 0.36% of the outstanding shares have been sold short.
| Short Interest | 52,408 |
| Short Previous Month | 58,242 |
| Short % of Shares Out | 0.36% |
| Short % of Float | 0.65% |
| Short Ratio (days to cover) | 2.97 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -15.37M |
| Pretax Income | -15.75M |
| Net Income | -15.02M |
| EBITDA | -15.37M |
| EBIT | -15.37M |
| Earnings Per Share (EPS) | -$1.61 |
Full Income StatementBalance Sheet
The company has $5.79 million in cash and $84,164 in debt, giving a net cash position of $5.70 million or $0.40 per share.
| Cash & Cash Equivalents | 5.79M |
| Total Debt | 84,164 |
| Net Cash | 5.70M |
| Net Cash Per Share | $0.40 |
| Equity (Book Value) | 3.94M |
| Book Value Per Share | 0.33 |
| Working Capital | 3.22M |
Full Balance SheetCash Flow
| Operating Cash Flow | -12.32M |
| Capital Expenditures | n/a |
| Free Cash Flow | -12.32M |
| FCF Per Share | -$0.85 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |